Bormioli Pharma

Company Profile

Bormioli Pharma is in continuous expansion. Its strategic importance is testified to by its various different plants scattered across Europe, and by the number of prestigious collaborations it enjoys with many of the most important pharmaceutical companies.

Bormioli Pharma is globally renowned for the quality and degree of innovation of its products. The company currently employs over 900 people, and runs 5 plants specialized in the manufacture of glass and plastic packaging.

Bormioli Pharma offers a huge range of glass packaging for the pharmaceutical market, and stands out for its quality, technological innovation and commercial services. It boasts state-of-the-art manufacturing facilities, including 6 furnaces dedicated to the creation of both tubular and molded glass packaging products.

Our product range is completed by a broad spectrum of plastic packaging solutions for the pharmaceutical, cosmetics and food sectors. This too is based on highly sophisticated materials and technologies that guarantee our ability to satisfy the need for chemical stability, dimensional precision and mechanical resistance... not forgetting practicality and design factors.

In its untiring quest for quality, Bormioli Pharma focuses strongly on personnel programs, implements the strictest manufacturing procedures and constantly invests in technologies and facilities; from clean rooms for preventing particle contamination to increasingly efficient and sophisticated control systems.

All this in order to ensure packaging products that fully comply both with client company specifications and elevated health and hygiene standards. A precise mission lies behind these demanding commitments: to stand by the side of pharmaceutical companies and satisfy every request for improvement and product packaging need.

About Triton

Building better businesses

Bormioli Pharma is owned by Triton since 2017.

Triton is an international investment firm, founded in 1997. The company seeks to contribute to building better businesses for the longer term through partnership.

Triton invests in medium-sized businesses with management located in Europe that fall within the Industrial, Business Services and Consumer/Health sectors.

Triton funds’ approximately 100 investors include, among others, pension funds, sovereign wealth funds, insurance companies and endowments. Triton includes environmental, social and governance criteria into investment considerations and decision-making processes which help to capture long-term value.

Since its founding, Triton has completed more than 60 investments and supported more than 260 acquisitions.

For more information, please visit:


Bormioli Pharma's product range includes glass and plastic vials, closure systems, containers and accessories for antibiotics, infusions, syrups, drops, pills and reagents. The range is completed by Bormioli's plastic packaging products for the cosmetics and food sectors. As well as constantly expanding and enhancing its standard range of products, Bormioli Pharma also produces customized packaging and develops new materials and innovative solutions.


In the course of its many operational activities, the company keeps a close eye on market evolution and also on environmental issues.


The company is certified to ISO 9001:2008 and ISO 15378. This latter certification guarantees that the activity and organisation of the production sites complies with international Good Manufacturing Practice standards, with reference to primary packaging for medicinal products. Bormioli Pharma has also been awarded certification for compliance with European Directive 93/42 EEC for medical devices . Furthermore the company is registered with international control bodies such as FDA for the United States market, TPP for Canada and SDA for China.


This site uses cookies, essential for the operation of the site and instrumental to the purposes stated in the Cookies Policy. The site utilizes analytics cookies, which enable the collection of information on how visitors use the website and how they have accessed it, also on the number and duration of the visits made, as well as allowing "third party" cookies to be sent. This link accesses the full cookies policy statement, which provides indications concerning the use of technical and analytics cookies and explains the procedure for choosing which specific cookies to authorize. On the page displaying the full statement, a user can refuse permission to install cookies of any description. The decision to continue browsing — evidenced by closing this banner, scrolling the present page, accessing another area of the site or selecting an element of the content (for example, clicking an image or a link) — indicates that consent is given to the use of cookies.